Streamex Corp.

Streamex Corp. specializes in tokenized finance and real-world asset (RWA) digitization, primarily through its Streamex operations. The company was originally formed as a Nevada corporation in February 2009, reincorporated in Delaware in April 2011, and changed its name from BioSig Technologies, Inc. to Streamex Corp. on September 12, 2025. On the same date, its common stock began trading on The Nasdaq Capital Market under the ticker symbol "STEX," replacing "BSGM." On May 28, 2025, Streamex Corp. acquired Streamex Exchange Corporation, a British Columbia corporation formed on April 5, 2024. This acquisition involved the issuance of exchangeable shares by the Company's wholly owned British Columbia unlimited liability company subsidiary ("ExchangeCo"). These exchangeable shares are convertible on a one-for-one basis, subject to adjustments, into shares of the Company's common stock. Holders of these shares are entitled to exchange them for an aggregate of 109,070,039 shares of the Company's common stock, representing up to 75% of the Company's fully diluted common stock as of the agreement date. Shareholder approval on November 4, 2025, removed the conversion cap, allowing full exchange of these shares. In addition to its primary business, Streamex Corp. maintains a legacy healthcare technology innovation segment. This segment focuses on advanced signal acquisition and analysis, utilizing the Company's PURE EP™ platform. To explore further applications of its signal processing technology beyond cardiac electrophysiology, the Company formed a Delaware subsidiary, originally named NeuroClear Technologies, Inc., on November 7, 2018.